These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 14644663)

  • 1. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.
    Olsen GW; Church TR; Miller JP; Burris JM; Hansen KJ; Lundberg JK; Armitage JB; Herron RM; Medhdizadehkashi Z; Nobiletti JB; O'Neill EM; Mandel JH; Zobel LR
    Environ Health Perspect; 2003 Dec; 111(16):1892-901. PubMed ID: 14644663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington.
    Olsen GW; Church TR; Larson EB; van Belle G; Lundberg JK; Hansen KJ; Burris JM; Mandel JH; Zobel LR
    Chemosphere; 2004 Mar; 54(11):1599-611. PubMed ID: 14675839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood.
    Olsen GW; Huang HY; Helzlsouer KJ; Hansen KJ; Butenhoff JL; Mandel JH
    Environ Health Perspect; 2005 May; 113(5):539-45. PubMed ID: 15866760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006.
    Olsen GW; Mair DC; Church TR; Ellefson ME; Reagen WK; Boyd TM; Herron RM; Medhdizadehkashi Z; Nobiletti JB; Rios JA; Butenhoff JL; Zobel LR
    Environ Sci Technol; 2008 Jul; 42(13):4989-95. PubMed ID: 18678038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.
    Kannan K; Corsolini S; Falandysz J; Fillmann G; Kumar KS; Loganathan BG; Mohd MA; Olivero J; Van Wouwe N; Yang JH; Aldoust KM
    Environ Sci Technol; 2004 Sep; 38(17):4489-95. PubMed ID: 15461154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors.
    Olsen GW; Mair DC; Reagen WK; Ellefson ME; Ehresman DJ; Butenhoff JL; Zobel LR
    Chemosphere; 2007 May; 68(1):105-11. PubMed ID: 17267015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals.
    Ehresman DJ; Froehlich JW; Olsen GW; Chang SC; Butenhoff JL
    Environ Res; 2007 Feb; 103(2):176-84. PubMed ID: 16893538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends of perfluoroalkyl concentrations in American Red Cross adult blood donors, 2000-2010.
    Olsen GW; Lange CC; Ellefson ME; Mair DC; Church TR; Goldberg CL; Herron RM; Medhdizadehkashi Z; Nobiletti JB; Rios JA; Reagen WK; Zobel LR
    Environ Sci Technol; 2012 Jun; 46(11):6330-8. PubMed ID: 22554481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations.
    Olsen GW; Burris JM; Burlew MM; Mandel JH
    J Occup Environ Med; 2003 Mar; 45(3):260-70. PubMed ID: 12661183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An occupational exposure assessment of a perfluorooctanesulfonyl fluoride production site: biomonitoring.
    Olsen GW; Logan PW; Hansen KJ; Simpson CA; Burris JM; Burlew MM; Vorarath PP; Venkateswarlu P; Schumpert JC; Mandel JH
    AIHA J (Fairfax, Va); 2003; 64(5):651-9. PubMed ID: 14521435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals.
    Olsen GW; Hansen KJ; Stevenson LA; Burris JM; Mandel JH
    Environ Sci Technol; 2003 Mar; 37(5):888-91. PubMed ID: 12666917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorooctanesulfonate (PFOS) Conversion from N-Ethyl-N-(2-hydroxyethyl)-perfluorooctanesulfonamide (EtFOSE) in male Sprague Dawley rats after inhalation exposure.
    Chang S; Mader BT; Lindstrom KR; Lange CC; Hart JA; Kestner TA; Schulz JF; Ehresman DJ; Butenhoff JL
    Environ Res; 2017 May; 155():307-313. PubMed ID: 28260617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000-2015.
    Olsen GW; Mair DC; Lange CC; Harrington LM; Church TR; Goldberg CL; Herron RM; Hanna H; Nobiletti JB; Rios JA; Reagen WK; Ley CA
    Environ Res; 2017 Aug; 157():87-95. PubMed ID: 28528142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The applicability of biomonitoring data for perfluorooctanesulfonate to the environmental public health continuum.
    Butenhoff JL; Olsen GW; Pfahles-Hutchens A
    Environ Health Perspect; 2006 Nov; 114(11):1776-82. PubMed ID: 17107867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population.
    Midasch O; Schettgen T; Angerer J
    Int J Hyg Environ Health; 2006 Nov; 209(6):489-96. PubMed ID: 16872899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians.
    Kubwabo C; Vais N; Benoit FM
    J Environ Monit; 2004 Jun; 6(6):540-5. PubMed ID: 15173906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends of perfluorooctanesulfonate isomer and enantiomer patterns in archived Swedish and American serum samples.
    Liu Y; Pereira AS; Beesoon S; Vestergren R; Berger U; Olsen GW; Glynn A; Martin JW
    Environ Int; 2015 Feb; 75():215-22. PubMed ID: 25490284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomer fractions of chiral Perfluorooctanesulfonate (PFOS) in human sera.
    Wang Y; Beesoon S; Benskin JP; De Silva AO; Genuis SJ; Martin JW
    Environ Sci Technol; 2011 Oct; 45(20):8907-14. PubMed ID: 21882865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Serum Lipid, Thyroid, and Hepatic Clinical Chemistries in Association With Serum Perfluorooctanesulfonate (PFOS) in Cynomolgus Monkeys After Oral Dosing With Potassium PFOS.
    Chang S; Allen BC; Andres KL; Ehresman DJ; Falvo R; Provencher A; Olsen GW; Butenhoff JL
    Toxicol Sci; 2017 Apr; 156(2):387-401. PubMed ID: 28115654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorooctanesulfonate and perfluorooctanoic acid exposures of the Italian general population.
    Ingelido AM; Marra V; Abballe A; Valentini S; Iacovella N; Barbieri P; Porpora MG; Domenico Ad; De Felip E
    Chemosphere; 2010 Aug; 80(10):1125-30. PubMed ID: 20633921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.